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HISTORICAL PERSPECTIVE
The history of endoscopic skull base surgery is de facto the his-
tory of pituitary surgery. The first pituitary operation was likely
performed by Sir Victor Horsley in 1889 via a transfrontal approach
though he did not publish his results (1). His compatriots, Caton
and Paul, were the first to publish the results of this operation in
1893 (2) in which they reported that their patient was cured of
his headaches for the three months he survived post operative-
ly. But, it is Schloffer who is widely regarded as the father of
modern pituitary surgery. In 1906 he published a seminal paper
discussing the possibility of pituitary surgery via a transsphenoidal
approach (3) and performed this operation on March 16, 1907.
The operation was performed via nasal translocation and lasted
about 75 min. Though there were no intraoperative complica-
tions, the patient died two months later and on autopsy was
found to have hydrocephalus as a result of residual tumor block-
ing the foramen of Monro (4). Then in 1910, Oskar Hirsh, an oto-
laryngologist, introduced a transseptal, transsphenoidal approach
to the pituitary gland (5), an operation which is still in use today.
Cushing performed his first pituitary operation in 1909 (6) using
Schloffer’s method but then rapidly adopted Hirsh’s approach
adding a sublabial incision and a headlamp to improve visual-
ization of the sella. Using this approach he performed 231 oper-
ations with a 5.6% mortality rate (7, 8). However, because of
difficulties with cerebrospinal fluid (CSF) leak, hemorrhage con-
trol, post operative cerebral edema, and concerns regarding vision
outcomes and recurrence he eventually abandoned the transsphe-
noidal approach and went to a transcranial approach. This was a
large setback for the transsphenoidal approach as it led to the
vast majority of pituitary operations being performed transcra-
nially for the next 35 yr.
During this period, the transsphenoidal approach was cham-
pioned by two surgeons. Hirsch continued to perform transphe-
noidal hypophysectomy and by 1937 had performed the opera-
tion on 277 patients with a mortality rate of 5.4% (9). After being
displaced from Austria by the Nazis shortly thereafter, he emi-
grated to the US and continued to operate at Massachusetts Ge-
neral Hospital in collaboration with a neurosurgeon, Hannibal
Hamlin. The other surgeon who kept the technique alive was
Norman Dott, a British neurosurgeon who learned the approach
in 1923 from Cushing and by 1956 had performed 80 procedures
with no deaths (8).
The modern advent of the transsphenoidal approach as the pre-
ferred approach to the pituitary began in 1956 when a French
neurosurgeon, Gerard Guiot, learned the technique from Dott
and brought it back to Paris and reintroduced it to skeptical col-
leagues. He ultimately performed over 1,000 transsphenoidal
hypophysectomies and also introduced the use of intraoperative
fluoroscopy (8, 10, 11). A student of Giuot, Jules Hardy revolu-
tionized the transsphenoidal pituitary approach when he intro-
duced the use of the operating microscope and microsurgical in-
strumentation in 1967. The microscope with increased illumina-
tion and magnification permitted a more thorough and safer resec-
tion without deaths or major morbidities (10, 11). Indeed, Hardy’s
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Endoscopic skull base surgery has undergone rapid advancement in the past decade moving from pituitary surgery to suprasel-
lar lesions and now to a myriad of lesions extending from the cribriform plate to C2 and laterally out to the infratemporal
fossa and petrous apex. Evolution of several technological advances as well as advances in understanding of endoscopic
anatomy and the development of surgical techniques both in resection and reconstruction have fostered this capability.
Management of benign disease via endoscopic methods is largely accepted now but more data is needed before the con-
troversy on the role of endoscopic management of malignant disease is decided. Continued advances in surgical technique,
navigation systems, endoscopic imaging technology, and robotics assure continued brisk evolution in this expanding field.
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Reviewcontributions led to a paradigm shift in pituitary tumor surgery.
Previously, the operation was performed to debulk large tumors
off the optic apparatus, but now microsurgical techniques were
introduced allowing for surgical cure of hormonal disease in mic-
roadenomas.
Although the procedure described by Hardy underwent numer-
ous modifications (including extended approaches to other skull
base sites: clival and suprasellar tumors as well as cavernous sinus
lesions), it was the main procedure performed by neurosurgeons
for removal of pituitary tumors from the 1960’s through the early
1990’s.
The dawn of endoscopic pituitary and skull base surgery was
dependent on several technological advances, the most obvious
of which is the endoscope. The first endoscope is credited to Philipp
Bozzini, a German physician, who demonstrated the “Lichtleiter”,
a candlelit tube, in 1806 to the Academy of Medicine in Vienna
(12). This was vastly improved in 1877 by Max Nitze, a German
urologist, with the addition of lenses for magnification and an
internal light source noting “to light up a room one must carry
the lamp inside (13).” His first endoscope used a water-cooled
platinum wire for illumination but Edison’s invention of the incan-
descent bulb in 1879 allowed the development of a cystoscope
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Fig. 1. Image guidance navigation system showing fusion of MRI and
CT. The fusion of CT and MRI data allows the surgeon to have infor-
mation on bony anatomy, tumor position and size, as well as location
of critical structures such as the carotid artery and optic nerve.
Fig. 2. Sellar opening. (A) After the sphenoid sinus is wide opened, the sella is drilled with an irrigating drill with a diamond burr until the bone is
eggshell thin. (B) Thin bone is then fractured and removed with curettes. (C) Bony opening is then enlarged with kerrison rongeurs. (D) After the
dura is exposed, bipolar coagulation is performed before opening of the dura.
A B
D Cthat no longer required water cooling. Using his invention, Nitze
was the first person to perform endoscopic surgery with wire loops
and to take endoscopic pictures. The next technological break-
through occurred almost a century later when Harold Hopkins
in 1960 vastly improved optical efficiency by inserting glass rods
and neutral gas between the lenses. Around the same time, Basil
Hirschowitz, an American gastroenterologist, developed a flex-
ible endoscope using fiberoptics. The modern rigid endoscope was
invented by Karl Storz in 1965 when he combined the optical
rod system of Hopkins and used fiberoptics to carry illumination
down to the tip of the endoscope (14). This endoscope allowed
radically improved visualization offering magnified panoramic
views from the tip of a narrow caliber instrument. Other impor-
tant developments included the invention of computed tomog-
raphy, image guidance systems (Fig. 1), powered instrumentation
(Fig. 2) and the charged coupled device camera.
In 1901, Hirschman used a modified cystoscope to inspect the
maxillary sinus but it was not until the modern endoscope was
invented that endoscopic surgery of the paranasal sinuses became
practical. This started with Messerklinger who in the 1970s pub-
lished seminal work on endoscopic diagnosis and management
of inflammatory disease of the sinuses (15). Endoscopic surgery
of the paranasal sinuses rapidly advanced and was popularized
by the work of Kennedy, Stammberger and others starting in the
1980s. Its use in pituitary surgery was actually first mentioned
as a complementary procedure by Guiot, however, widespread
use of the endoscope in pituitary surgery did not follow (10).
Endoscopic surgery of the pituitary was revisited by Jankowski
in 1992 (16) but it was the landmark paper by Jho and Carrau
in 1997 that marked the beginning of modern endoscopic pitu-
itary surgery. In their series of 50 patients, they reported the results
of 48 operations which were purely endonasal, endoscopic, tra-
nssphenoidal approaches to the pituitary and noted the safety,
efficacy and decreased morbidity of this technique (17). This was
quickly followed by a report by Cappabianca et al. who devel-
oped dedicated endoscopic equipment and suggested technical
improvements (18). It is now clear that compared to transsphe-
noidal surgery using an operative microscope, endoscopic surgery
offers shorter operative times, less intraoperative blood loss, supe-
rior differentiation between normal glandular tissue and tumor,
better images of intrasellar and parasellar structures, reduced hos-
pital stay, improved patient satisfaction, and decreased need for
nasal packing (9).
It was not long afterward that endoscopic approaches beyond
the sella were described. Access to the suprasellar lesions by tak-
ing down the planum sphenoidale using a microscope was decribed
by Laws et al. in 1980 (19) and this same approach was adapted
for endoscopy. Descriptions of endoscopic access to the cavernous
sinus, clivus, odontoid process, pterygopalatine fossa, petrous apex,
and midline anterior cranial fossa have now all be published (20-
41). These more advanced skull base operations require the use
of two surgeons operating with four hands (Fig. 3).
There are several distinct anatomic regions of the skull base
that are accessible via a transnasal endoscopic approach: cribri-
form, parasellar, clivus, spinomedullary junction, petrous apex,
pterygopalatine and infratemporal fossa. It is useful to consider
each region separately as each has its own set of anatomic con-
straints and indeed, a modular system of approaches based on
these anatomic subunits have been proposed by Kassam et al.
(29-31). In addition, there are specific histopathologies that are
more commonly encountered in each region.
CRIBRIFORM LESIONS
Lesions that involve the cribriform plate include olfactory groove
meningioma, esthesioneuroblastoma, adenocarcinoma, squamous
cell carcinoma, sinonasal undifferentiated carcinoma, mucosal
melanoma and many others. Of these rare lesions, the most pub-
lished data on endoscopic resection is on esthesioneuroblastomas.
There are several cases series on endoscopic resection of esthe-
sioneuroblastomas but each report only represents a handful of
patients. Unger et al. first published a series of six patients treated
endoscopically and with a followup of 57 months, they achieved
100% disease specific survival (36). Surgical margins were not
obtained in that study but no obvious disease was left behind.
Poetker et al. reported on 5 cases with 2 recurrences, both in Kadish
C disease (42). Their report on 40 patients included 24 with benign
pathology, mostly inverting papilloma, and 16 with malignant
pathology, mostly esthesioneuroblastoma. The recurrence rate
was 4% for benign disease and 31% for malignant disease with
a mean followup of 22 and 51 months respectively. Lund et al.
found overall survival of 89% and disease free survival of 56%
in a cohort of 11 patients treated endoscopically (43). This series
was limited to patients with Kadish A and B disease with the
author’s current preference for open craniofacial resection for
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Fig. 3. Four hand technique. One surgeon generally holds the endo-
scope and a suction while the other surgeon dissects with two hands.
In this picture, the teaching surgeon is reaching in with forceps to remove
specimen for frozen section.Kadish C diease. Another report on 18 patients treated over a
25 yr period had 3 patients treated with endoscopic resection, of
which one patient had two recurrences and ultimately under-
went open craniofacial resection (44). Castelnuovo et al. have
also described their experience in ten patients who underwent
endoscopic resection, all with negative margins and no local recur-
rences with median follow up of 37 months (45). They were able
to save olfactory function in all their patients by performing a
unilateral cribform excision and sparing the contralateral cribri-
form plate, an idea that has been advocated by other authors
(46). Similarly, another Italian group treated nine patients with
no evidence of disease with a mean followup of 42 months (47).
That study only included Kadish A and B disease as the authors
felt as Lund et al. that Kadish C disease was best treated by tra-
ditional craniofacial resection. Dave et al. treated nine patients
with one recurrence (46). The lack of en bloc resection has often
been a criticism of endoscopic surgery when managing malignant
disease (48) however, in this study, the authors were able to achieve
what they considered to be en bloc resection in about half of their
patients and negative margins in all patients. Also, many authors
have suggested that piecemeal resection does not appear to affect
patient outcomes provided that negative margins are ultimately
achieved (46, 49-51). Others have suggested that though en bloc
tumor removal is not important, en bloc removal of the area of
invasion or tumor origin is crucial (52). The most recently pub-
lished data on 23 patients of all Kadish stages treated at University
of Miami and University of Pittsburgh demonstrated no evidence
of disease in 22 patients with a mean followup of 37 months (52).
It is important to note that recurrences in esthesioneuroblastoma
can occur 10 to 20 yr later (53) and therefore the true efficacy
of endoscopic resection cannot be compared to formal open
craniofacial resection until sufficient followup has been achieved.
Advantages of endoscopic resection include improved cosme-
sis, reduced brain manipulation, lower morbidity, shorter surgi-
cal time, quicker recovery and shorter hospital stay, ability to
precisely localize tumor origin which can be surprisingly focused
despite bulky disease (43, 46, 49). Involvement of facial skin,
need for orbital exenteration, extensive lateral extension have
been mentioned as contraindications to an endoscopic resection
of these lesions (44).
PARASELLAR LESIONS
Parasellar lesions include meningiomas, craniopharyngiomas,
epidermoid cysts, and pituitary macroadenomas. Endoscopically,
these are accessed by transgressing the planum sphenoidale, tuber-
culum sphenoidale and/or the sella turcica (Fig. 4). For pituitary
macroadenomas without extensive suprasellar extension, transnasal
endoscopic resection clearly is both safe and efficacious making
it the preferred method of extirpation (9, 54). In our experience
with parasellar lesions, we have discovered that hydroscopy is
useful in determining intraoperatively, the completeness of resec-
tion. Hydroscopy is performed by irrigating the field with normal
saline under gentle pressure which lifts tissues out of the way,
washes away minimal bleeding and distends the cavity to allow
for complete inspection (Fig. 5). Craniopharyngiomas are benign
epithelial tumors that account for 2-5% of all intracranial neo-
plasms and routinely have a significant suprasellar component.
Though they are benign tumors, they tend to have serious con-
sequences due to their location near vital intracranial structures
and optimal treatment protocols remain controversial. It is clear
that gross total removal of the tumor is superior to partial removal
or evacuation with 10 yr disease free of 100% for patients with
gross total removal and 38% and 77% respectively for patients
with partial removal and partial removal with radiotherapy (55).
Some have advocated gross total removal in all circumstances
while others have suggested that the risks of total removal be
weighed against the morbidity of more aggressive surgical inter-
vention. Traditional approaches to suprasellar lesions include the
subfrontal and the pterional approach, both of with are restrict-
ed by the optic chiasm making its relative position, pre or post
fixed, of surgical importance. However, the position of the optic
chiasm has been found to be of relatively less importance when
the lesion is approached from below via an endoscopic approach
and a classification scheme based on position of the lesion rela-
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Fig. 4. Removal of tuberculum meningioma. Preop and post op MRI of
a tuberculum meningioma which was recurrent after a resection sev-
eral years ago via a subfrontal craniotomy approach. This was resect-
ed via a transplanum approach. In the endoscopic view, the carotids
(C) and optic nerves (ON) are marked as seen during tumor dissection.
Preop Postop
ON ON
C Ctive to the infundibulum has been proposed (56). “Type I is pre-
infundibular; Type II is transinfundibular (extending into the stalk);
Type III is retroinfundibular, extending behind the gland and stalk,
and has 2 subdivisions (IIIa, extending into the third ventricle;
and IIIb, extending into the interpeduncular cistern); and Type
IV is isolated to the third ventricle and/or optic recess and is not
accessible via an endonasal approach.” The same authors have
also proposed an endoscopic transposition of the pituitary to
reach Type IIIb lesions that extend into the interpeduncular cis-
tern (57). Using this approach, they were able to achieve greater
than 95% resection of four craniopharyngiomas, two of which
were recurrences, with improvement of visual function in all and
loss of pituitary function in one. Laufer et al. removed 10 suprasel-
lar lesions, mostly craniopharyngiomas and meningiomas, and
achieved visual function improvement in all patients with pre-
operative deficits with a 10% CSF leak rate and 40% panhypopi-
tuitarism rate (58). Frank et al. presented a series of 10 patients
with craniopharyngiomas in 2006 where they achieved total resec-
tion in 70% with visual function improvement in all. Their com-
plications were CSF leak in 30%, permanent endocrine dysfunc-
tion in 30% and one patient had meningitis (59). De Divitiis et
al. had similar results in 20 patients who underwent transnasal
endoscopic resection of various suprasellar lesions. All but one
patient had improved or unchanged vision. Total resection was
achieved in 16. There was a 5% incidence of CSF leak and 25%
incidence of postoperative endocrine dysfunction (60). The same
authors published another report on suprasellar craniopharyn-
giomas that added 3 patients to the previous series which had 7
cases of that pathology for a total of 10 patients. In this cohort,
total resection was achieved in 70% and visual function was im-
proved or unchanged in all except one patient who had improve-
ment in one eye and worsening in the other. Complications were
a 20% CSF leak rate, 30% rate of endocrine dysfunction and
one patient with brainstem hemorrhage 5 weeks post op result-
ing in death (61). The most recent series is on seven patients where
total resection was achieved in 57% and visual function improved
in 67%. Complications in that series were a CSF leak rate of 28.6%
and no incidence of permanent endocrine dysfunction (62). Lesions
in this area are well suited to endoscopic removal as all approach-
es transverse a large distance due to the central location of the
parasellar region. Microscopic techniques suffer from progressive
narrowing of the field of view as distance increases while the
endoscope is able to provide a panoramic view due to its ability
to deliver light and receive optical input at the distal end of the
scope. This allows improved visualization of the lesion and neu-
rovascular structures. Advantages of the endoscopic approach
are decreased nasal morbidity when compared to microscopic
transsphenoidal approaches, decreased brain manipulation when
compared to transcranial approaches, and less need to work around
major neurovascular structures when compared to the transcra-
nial approaches. Poor pneumatization of the sphenoid sinus has
been noted as a possible contraindication to the endoscopic ap-
proach as well as extension far into the third ventricle or adher-
ence to neurovascular structures. The efficacy of endoscopic resec-
tion of suprasellar lesions appears to compare favorably to more
traditional approaches however longer followup and larger num-
bers are required to truly address that question.
CLIVAL LESIONS
The major lesions of the clivus are chordomas and chondrosar-
comas. Chordomas are a rare tumor of the skull base represent-
ing less than 1% of intracranial tumors. They arise from remnants
of the embryonic notochord and though they rarely metastasize,
they have a propensity for local recurrence and insinuation into
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Fig. 5. Hydroscopy. In this case hydroscopy was performed after removal of a giant pituitary adenoma by irrigating the sella with normal saline
and using a 45 deg endoscope to obtain 360 deg views around the entire periphery to confirm no residual pockets of tumor. (A) The cav-
ernous carotid (C) and cavernous sinus (CS) are seen. (B) View of the floor of the sella.
A B
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Cbone along lines of least resistance. On average, untreated chor-
domas result in death approximately two years after diagnosis
and even with aggressive treatment prognosis is poor with 10
yr survival between 18% and 35%. Chondrosarcomas are
even less common tumors of the skull base that are thought to
arise either from primitive mesenchymal cells or embryonic rests
of cartilage at the skull base (63). The optimal treatment for these
lesions appears to be gross total surgical resection followed by
proton therapy (64). The clivus is most easily approached transphe-
noidally however the narrowing field of view using a microscope
from this anterior approach made pterional and retrosigmoid
approaches necessary for tumors with significant lateral exten-
sion. Despite this weakness, the transphenoidal approach is the
most commonly used approach for resection of these tumors.
Several reports of endoscopic resection of these lesions have been
published (20, 24, 57, 65-67). The largest series represents 11
patients with a mean followup of 27 months (65). They report-
ed radical resection in 5 patients one of which was in a recurrent
tumor that had been previously treated with surgery. Seven
patients were free of disease at last followup and no patients
suffered neurologic deficits post operatively. Their complications
included one internal carotid artery (ICA) injury necessitating
an aborted operation and subsequent endovascular repair and
two CSF leaks. Another series looked at four patients with chor-
domas located in the interpeduncular cistern. That study report-
ed total resection in 75% and complication included transient
cranial nerve VI (CN VI) palsy and a 75% CSF leak rate. Unfor-
tunately, followup data on possible recurrence was not present-
ed (57). The most recent study demonstrated no evidence of
disease in seven of nine patients treated endoscopically with a
followup period ranging from 3 to 39 months (20). The data on
efficacy of endoscopic resection in these lesions is still evolving
and obviously, longer followup and greater numbers are need-
ed before any meaningful comparison to historical data can be
performed. However, the data produced to date is promising
and postoperative complication rates are favorable when com-
pared to other approaches.
SPINOMEDULLARY JUNCTION LESIONS
The most common surgical lesion of this region is odontoid pan-
nus usually secondary to rheumatoid arthritis. Traditionally, this
is approached via a transoral route. An endoscopic endonasal
approach to this area was first proposed by Alfieri et al. (68) using
cadaveric studies. The first such operation was reported in 2005
(39) and since then several other groups have reported success
with similar procedures (69-71). The major advantages of the
endonasal route include quicker recovery, faster return to oral
alimentation, lower incidence of velopharyngeal insufficiency
with the major drawback being limitation at the caudal end of
the dissection making the procedure not available to all patients.
Preop radiographic evaluation can determine whether or not a
given patient’s anatomy is amenable to this approach (72).
Another lesion, nasopharyngeal carcinoma is treated primari-
ly with radiation however surgical salvage is the only possibly
curative option left to patients who fail radiotherapy. A recent
study of six patients suggests that endoscopic resection of rT1
and rT2a disease can be effective with a local control rate of
83.3% with a mean followup of 29 months (73).
PETROUS APEX LESIONS
The classic lesion of this area is the cholesterol granuloma how-
ever chordomas, chondrosarcomas and meningiomas are also
among the lesions found here. The first description of endo-
scopic transsphenoidal management of a petrous apex choles-
terol granuloma was by Griffith et al. (40). Since then several
other groups have reported their experience with this tech-
nique (21, 34, 74-76). Traditional routes to the petrous apex
have included transmastoid approaches that must navigate
around the facial nerve and part or all of the otic capsule or
middle fossa approaches that involve brain retraction and cran-
iotomy. The transsphenoidal approach can be faster and safer
but only in selected cases. Anatomic variability in pneumatiza-
tion of the temporal and sphenoid bone along with the location
of the lesion and the carotid should be used to guide what is the
best approach.
PTERYGOPALATINE AND INFRATEMPORAL
FOSSAL LESIONS
This region represents the lateral extent of endoscopic approaches
thus far and is host to lesions such as paragangliomas, schwanno-
mas, sphenoid wing meningiomas, and juvenile nasopharyngeal
angiofibromas (Fig. 6). There are several reports of such lesions
being removed endoscopically (77-79). A recent review on endo-
scopic management of juvenile nasopharyngeal angiofibromas
concluded that the vast majority of these lesions can be managed
safely and effectively via an endoscopic approach (80). The major
concerns with endoscopic surgery in this region are the difficulty
in controlling hemorrhage from the abundant and highly vari-
able vasculature and difficulty in physically accessing the lesion
as the dissection proceeds more laterally (29).
RECONSTRUCTION
One of the major concerns in endoscopic skull base surgery is
the need for robust reconstruction of the dural defect. The tech-
nology and techniques to create large defects in the cranial base
have been available for quite some time. However, it is only
58 Clinical and Experimental Otorhinolaryngology  Vol. 1, No. 2: 53-62, June 2008recently that good options for reconstruction have been discov-
ered. The early attempts at skull base reconstruction evolved
from experience in dealing with CSF leaks and encephaloceles
(Fig. 7) endoscopically (81-85). These methods utilized various
materials such as dermal grafts, acellular dermis, free mucosal
grafts, cartilage, fat, bone and fascia often in multiple layers to
close defects at the skull base. Based on the reports, regardless of
the material used, there was high success with these techniques
for small defects. As defects became larger, the success of recon-
struction with these techniques decreased leading to unaccept-
ably high rates of CSF leak in large endoscopic skull base pro-
cedures (86). In open skull base surgery, vascularized flaps such
as the pericranial flap, temporoparietal flap and free flaps are
available as reconstructive options and it became clear that a
vascularized flap was necessary to ensure reliable reconstruction
of larger defects. The first such option was a septal mucosal flap
based posteriorly off the posterior septal artery (87). This recon-
structive option is now the workhorse of endoscopic skull base
reconstruction and has dramatically improved CSF leaks rates
to rates comparable to open procedures. This option is not always
available. A more recent report described transposing the tem-
poroparietal flap through the infratemporal fossa and pterygopala-
tine fossa and then endoscopically placing the flap for reconstruc-
tion (88). Pericranial flaps can also be harvested endoscopically
and then transposed into the nasal cavity via a small osteotomy at
the nasion. The first report of such a reconstruction will soon be
published by University of Pittsburgh (personal communication).
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Fig. 6. Infratemporal fossa schwannoma. (A) Preop MRI of lesion. (B) Postop MRI of lesion. (C) Endoscopic view of schwannoma. (D) Lateral dis-
section. (E) Internal debulking. (F) Endoscopic view after resection demonstrating dehiscent dura and carotid. Patient has a well mucosalized
cavity and is free of recurrence at 9 month followup. (Pictures courtesy of Dr. Mark Weissler)
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Fig. 7. Lateral sphenoid sinus encephalocele. Encephaloceles are man-
aged by first placing a lumbar drain and instilling a dilute solution of
fluorescein intrathecally. This allows for definitive indentification of the
encephalocele and site of CSF drainage endoscopically. The ence-
phalocele is followed back to the skull base dehiscence with suction
and bipolar cautery and then bony defect is exposed and cleaned.
A strut of cartilage and bone is then placed across the bony defect
and then a mucosal graft is placed as an onlay graft and then tissue
glue and merocel sponges are used to secure the graft in place. In
this picture, the bipolar was placed through a transpterygoid port and
the fluorescein is clearly seen as well as the carotid canal.FUTURE DIRECTIONS
The limits of endoscopic skull base resection are still being defined
and as is often the case, the limits will likely not be realized until
we have exceeded them. However, changes in what is possible
and in techniques will likely come with changes in technology,
much as endoscopic surgery as we know it today was largely
driven by technological developments such as the Hopkins rod,
powered instrumentation, and image guidance systems. There
are several such developments on the horizon. Real time MRI
and intraoperative ultrasound guided compensation of naviga-
tion systems would be major improvements to current naviga-
tion systems and aid in assessment of intraoperative progress
during tumor resection (89, 90). Multidirectional rigid endoscopes
tied to virtual reality systems have been reported (91). Rigid
endoscopes with dual chip tips for three dimensional visualiza-
tion are also in the works. Robotic surgery could also transform
the way skull base surgery is performed. Currently, endoscopic
surgery is ergonomically unfavorable and technically difficult
with steric considerations not only in placement of the instru-
ments intranasally but in placement of four hands in a relative-
ly small area outside the nose. Also, current endoscopic instru-
ments used in skull base surgery have no wrist and therefore
have limited dexterity, although endoscopic instruments with
such capabilities have been developed for natural orifice trans-
luminal endoscopic surgery. Robotic surgery allows suturing
which would be useful in the reconstructive phase of the opera-
tion. Indeed, cadaveric studies demonstrating the feasibility and
advantages of robotic skull base surgery and one operation on an
infratemporal fossa lesion have been published (92, 93). Current
robotic systems were developed for thoracic and abdominal
surgery and their size and geometry are ill suited for transnasal
endoscopic skull base surgery however, this will change with
continued refinement of the systems. Looking at what’s ahead,
it is not difficult to imagine having a system that allows high dex-
terity surgical manipulation with a maneuverable three dimen-
sional endoscope being used for skull base surgery.
CONCLUSION
Transnasal endoscopic skull base surgery is a field that has expe-
rienced an explosion of development over the past several years
and is still being defined in terms of its scope. The range of anatom-
ic regions and pathology that can be addressed by endoscopic
approaches is already impressive and currently questions about
its efficacy are largely unanswered. For the treatment of benign
disease, endoscopic treatment has largely gained acceptance; it
is in malignant disease that endoscopic management remains
controversial and where data is most needed to answer these
concerns. However, this is a question that can only be answered
with more patients and longer followup will hopefully be seen
over the next several years. What we do know is that in experi-
enced hands, resection of disease is technically feasible and safe
when the disease has not spread beyond the limits of the technique:
caudal to the body of C2, anterior and superior to the frontal
outflow tract, lateral to the orbits, and anterior wall of the max-
illary sinus or superficial skin. It is important to keep in mind
that a minimally invasive approach should not be used as a rea-
son for minimal surgery. The extent of resection should be equal
or better than the extent of resection via an open approach and
if the surgeon feels that the endoscopic approach will limit the
completeness of surgery, an alternative approach should be uti-
lized. Finally, when considering the approach to use, generally
the approach that traverses the fewest neurovascular structures
to access the lesion will be the best approach. For the vast majori-
ty of midline skull base lesions, this will be the endoscopic approach
from below.
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